June 27, 2022
Washington, DC – Today, the Center for U.S. Policy published the following
statement in response to the unanimous decision of the U.S. Supreme Court in Ruan v. U.S.:
June 27, 2022
March 28, 2022
Thirty-three not-for-profit organizations sent a letter to commend Members of Congress for introducing a bill to provide Medicare coverage and create a new Medicaid payment category for prescription digital therapies. The “Access to Prescription Digital Therapeutics Act of 2022” is sponsored by Sens. Jeanne Shaheen (NH) and Shelley Moore Capito (WV), and Reps. Mike Thompson (CA-5) and David McKinley (WV-01).
March 23, 2022
The Center for U.S. Policy, Aimed Alliance, and the International Health Facility Diversion Association commended the federal government for facilitating patient access to prescription digital behavioral therapies. “We thank CMS for acting with speed to expand access to evidence-based digital therapies for behavioral health.”
January 20, 2022
Center for U.S. Policy Senior Fellow Lynn Webster, M.D. sent the following letter in response to Jim Rendon’s article in The Chronicle of Philanthropy entitled “How Nonprofits Helped Fuel the Opioid Crisis.”
January 7, 2022
CUSP, together with three other friends of the court, has filed an amicus brief asking the U.S. Supreme Court to end the federal government’s prosecutions of health care providers for unintentional prescribing errors. This case is “about the millions of people who need and use controlled medicines responsibly….”
November 18, 2021
A bill introduced in the U.S. House of Representatives would loosen federal restrictions on access to medication for opioid use disorder. The Improving Access to Care and Treatment (IMPACT) Act would increase the amount of time prescribers may store long-acting injectable (LAI) buprenorphine dispensed from a specialty pharmacy for administration to their patients.
October 21, 2021
Today, the Office of National Drug Control Policy (ONDCP) announced the release of a model law for state legislatures that would help ensure opioid litigation proceeds are directed to addressing substance use disorders and drug-related harms in impacted communities and with public accountability.
July 12, 2021
CUSP welcomes new senior fellow with focus on ensuring credible science, sound economics, and the rule of law underpin U.S. health and drug policy.
December 20, 2021
Center for U.S. Policy Senior Fellow Lynn Webster, M.D. sent the following letter to Margaret Brennan in response to her CBS News “Face the Nation” segment on the “other” crisis in America.
December 9, 2021
This week, the not-for-profit Center for U.S. Policy (CUSP) is urging the federal government not to pursue any claims it may have to state opioid litigation proceeds. “U.S. communities desperately need more resources to prevent and treat substance use disorders, provide compassionate care for people who use drugs, and support people in recovery.”
September 29, 2021
Mississippi’s ban on nearly all abortions after 15 weeks forces women to carry pregnancies to term under adverse circumstances and increases the risk of maternal mortality and other health problems, according to a public health amicus brief filed in the United States Supreme Court on September 20.
May 19, 2021
CUSP’s chairman tells PAINWeek that the federal government can improve drug policy by better addressing both demand for and supply of controlled medications and illicit substances.
December 15, 2020
Nonprofit tells Biden-Harris Transition Team that no woman has ever served as drug czar and states, “It is time for a woman to hold that position.”
November 11, 2020
CUSP’s chairman discusses the impact of the new RFP from the DEA that asks software contractors to create a nationwide data system that will increase the surveillance of prescriptions.
August 5, 2020
January 30, 2020
January 20, 2020
December 7, 2019
October 23, 2019
CUSP’s chairman discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.”
October 13, 2019
July 25, 2019
In recent years, the DEA has been increasing the number of raids on prescribers. CUSP’s chairman gives more insight into this rising problem.
July 14, 2019
Based on the assorted promotional claims of cannabidiol (CBD) product marketers, it appears that the truth about CBD’s benefits and risks depends on whom you ask and when.
FDA Must Change Course on Addiction Treatment Medications
April 25, 2019
CUSP’s chairman discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.
February 25, 2019
Three interconnected crises are currently happening in America: substance abuse, mental illness, and mass incarceration. All three can be curtailed by providing inmates with treatment and support during incarceration.
December 20, 2018
Looking forward to the 2020 campaign cycle and beyond, the United States is facing three large national crises: substance abuse, mental illness, and mass incarceration. All of these can be addressed if we fulfill an obligation required of us not only by the Constitution, but also by compassion and common sense.
Ruling on Affordable Care Act ‘Deeply Flawed’
December 17, 2018
Michael Barnes discusses the judicial decision deeming the Affordable Care Act unconstitutional and the potential impacts on consumers and states.